Eplerenone. Pharmacia.

  title={Eplerenone. Pharmacia.},
  author={Danny Liew and Jennifer Martin and Henry Krum},
  journal={Current opinion in investigational drugs},
  volume={4 3},
Pharmacia Corp (formerly GD Searle & Co) is developing eplerenone, an aldosterone receptor antagonist, as a potential treatment for congestive heart failure and systemic hypertension. The compound has been registered for hypertension and Pharmacia plans to submit a supplemental NDA for congestive heart failure in the first half of 2003 based on positive results from a phase III clinical trial. 

From This Paper

Topics from this paper.


Publications citing this paper.

Similar Papers

Loading similar papers…